266 related articles for article (PubMed ID: 18089795)
41. Accelerated cellular senescence in myelodysplastic syndrome.
Wang YY; Cen JN; He J; Shen HJ; Liu DD; Yao L; Qi XF; Chen ZX
Exp Hematol; 2009 Nov; 37(11):1310-7. PubMed ID: 19748549
[TBL] [Abstract][Full Text] [Related]
42. Myelodysplastic syndromes: from morphology to molecular biology. Part II. The molecular genetics of myelodysplasia.
Stephenson J; Mufti GJ; Yoshida Y
Int J Hematol; 1993 Apr; 57(2):99-112. PubMed ID: 8494999
[TBL] [Abstract][Full Text] [Related]
43. Analysis of mitochondrial DNA in 104 patients with myelodysplastic syndromes.
Wulfert M; Küpper AC; Tapprich C; Bottomley SS; Bowen D; Germing U; Haas R; Gattermann N
Exp Hematol; 2008 May; 36(5):577-86. PubMed ID: 18439489
[TBL] [Abstract][Full Text] [Related]
44. FLT3 mutation and AML/ETO in a case of Myelodysplastic syndrome in transformation corroborates the two hit model of leukemogenesis.
Pinheiro RF; Moreira Ede S; Silva MR; Greggio B; Alberto FL; Chauffaille Mde L
Leuk Res; 2007 Jul; 31(7):1015-8. PubMed ID: 17079011
[TBL] [Abstract][Full Text] [Related]
45. Transcriptosome and serum cytokine profiling of an atypical case of myelodysplastic syndrome with progression to acute myelogenous leukemia.
Mahadevan D; DiMento J; Croce KD; Riley C; George B; Fuchs D; Mathews T; Wilson C; Lobell M
Am J Hematol; 2006 Oct; 81(10):779-86. PubMed ID: 16838325
[TBL] [Abstract][Full Text] [Related]
46. Overexpression of N-Myc rapidly causes acute myeloid leukemia in mice.
Kawagoe H; Kandilci A; Kranenburg TA; Grosveld GC
Cancer Res; 2007 Nov; 67(22):10677-85. PubMed ID: 18006809
[TBL] [Abstract][Full Text] [Related]
47. Characteristics of novel myeloid precursor cell line, PC-MDS, established from a bone marrow of the patient with therapy-related myelodysplastic syndrome.
Bogdanović G; Jurisić V; Kraguljac N; Mrdjanović J; Jakimov D; Krtolica K; Krajnović M; Magić Z; Stojiljković B; Andrijević L; Srdić T; Baltić M; Popović S
Leuk Res; 2007 Aug; 31(8):1097-1105. PubMed ID: 17350682
[TBL] [Abstract][Full Text] [Related]
48. RAS mutations in myelodysplasia detected by amplification, oligonucleotide hybridization, and transformation.
Padua RA; Carter G; Hughes D; Gow J; Farr C; Oscier D; McCormick F; Jacobs A
Leukemia; 1988 Aug; 2(8):503-10. PubMed ID: 3166076
[TBL] [Abstract][Full Text] [Related]
49. Aberrant expression of p21RAS but not p120GAP is a common feature of myelodysplasia.
Gallagher A; Padua RA; al-Sabah A; Hoy T; Burnett AK; Darley RL
Leukemia; 1995 Nov; 9(11):1833-40. PubMed ID: 7475271
[TBL] [Abstract][Full Text] [Related]
50. Context Matters: Distinct Disease Outcomes as a Result of Crebbp Hemizygosity in Different Mouse Bone Marrow Compartments.
Zhou T; Perez SN; Cheng Z; Kinney MC; Lemieux ME; Scott LM; Rebel VI
PLoS One; 2016; 11(7):e0158649. PubMed ID: 27427906
[TBL] [Abstract][Full Text] [Related]
51. Myelodysplastic syndromes: molecular pathogenesis and genomic changes.
Nolte F; Hofmann WK
Ann Hematol; 2008 Oct; 87(10):777-95. PubMed ID: 18516602
[TBL] [Abstract][Full Text] [Related]
52. Gene stage-specific expression in the microenvironment of pediatric myelodysplastic syndromes.
Roela RA; Carraro DM; Brentani HP; Kaiano JH; Simão DF; Guarnieiro R; Lopes LF; Borojevic R; Brentani MM
Leuk Res; 2007 May; 31(5):579-89. PubMed ID: 17092558
[TBL] [Abstract][Full Text] [Related]
53. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome].
Yao DM; Qian J; Xu WR; Lin J; Jiang YW; Fei X; Han LX; Wang Y; Cen JN; Chen ZX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):36-9. PubMed ID: 18247301
[TBL] [Abstract][Full Text] [Related]
54. PUMA promotes apoptosis of hematopoietic progenitors driving leukemic progression in a mouse model of myelodysplasia.
Guirguis AA; Slape CI; Failla LM; Saw J; Tremblay CS; Powell DR; Rossello F; Wei A; Strasser A; Curtis DJ
Cell Death Differ; 2016 Jun; 23(6):1049-59. PubMed ID: 26742432
[TBL] [Abstract][Full Text] [Related]
55. Mutations of the PTPN11 gene in therapy-related MDS and AML with rare balanced chromosome translocations.
Christiansen DH; Desta F; Andersen MK; Pedersen-Bjergaard J
Genes Chromosomes Cancer; 2007 Jun; 46(6):517-21. PubMed ID: 17330262
[TBL] [Abstract][Full Text] [Related]
56. Mouse models of myelodysplastic syndromes.
Wegrzyn J; Lam JC; Karsan A
Leuk Res; 2011 Jul; 35(7):853-62. PubMed ID: 21466894
[TBL] [Abstract][Full Text] [Related]
57. Exisulind induces apoptosis in advanced myelodysplastic syndrome (MDS) and acute myeloid leukaemia/MDS.
Czibere A; Prall WC; Zerbini LF; Jäger M; Kobbe G; Knipp S; Libermann TA; Haas R; Aivado M
Br J Haematol; 2006 Nov; 135(3):355-7. PubMed ID: 16978222
[TBL] [Abstract][Full Text] [Related]
58. Human urine extract CDA-2 induces apoptosis of myelodysplastic syndrome-derived MUTZ-1 cells through the PI3K/Akt signaling pathway in a caspase-3-dependent manner.
Huang J; Yang M; Liu H; Jin J
Acta Pharmacol Sin; 2008 Aug; 29(8):951-64. PubMed ID: 18664328
[TBL] [Abstract][Full Text] [Related]
59. Combination of 5-azacytidine and thalidomide for the treatment of myelodysplastic syndromes and acute myeloid leukemia.
Raza A; Mehdi M; Mumtaz M; Ali F; Lascher S; Galili N
Cancer; 2008 Oct; 113(7):1596-604. PubMed ID: 18720364
[TBL] [Abstract][Full Text] [Related]
60. RAS, FLT3, and C-KIT mutations in immunophenotyped canine leukemias.
Usher SG; Radford AD; Villiers EJ; Blackwood L
Exp Hematol; 2009 Jan; 37(1):65-77. PubMed ID: 18977066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
